PetMed Express Inc (PETS)
4.21
+0.16
(+3.95%)
USD |
NASDAQ |
May 06, 16:00
4.205
0.00 (0.00%)
Pre-Market: 20:00
PetMed Express Enterprise Value: 39.60M for May 6, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 06, 2024 | 39.60M |
May 03, 2024 | 36.22M |
May 02, 2024 | 34.74M |
May 01, 2024 | 34.32M |
April 30, 2024 | 34.11M |
April 29, 2024 | 38.12M |
April 26, 2024 | 35.59M |
April 25, 2024 | 36.22M |
April 24, 2024 | 37.91M |
April 23, 2024 | 38.34M |
April 22, 2024 | 36.22M |
April 19, 2024 | 37.49M |
April 18, 2024 | 37.49M |
April 17, 2024 | 39.82M |
April 16, 2024 | 38.76M |
April 15, 2024 | 37.49M |
April 12, 2024 | 38.60M |
April 11, 2024 | 38.17M |
April 10, 2024 | 41.14M |
April 09, 2024 | 44.73M |
April 08, 2024 | 48.54M |
April 05, 2024 | 47.27M |
April 04, 2024 | 51.08M |
April 03, 2024 | 51.29M |
April 02, 2024 | 51.29M |
Date | Value |
---|---|
April 01, 2024 | 49.60M |
March 28, 2024 | 51.93M |
March 27, 2024 | 52.99M |
March 26, 2024 | 53.62M |
March 25, 2024 | 51.29M |
March 22, 2024 | 50.02M |
March 21, 2024 | 51.08M |
March 20, 2024 | 52.78M |
March 19, 2024 | 51.08M |
March 18, 2024 | 51.29M |
March 15, 2024 | 53.20M |
March 14, 2024 | 51.08M |
March 13, 2024 | 51.08M |
March 12, 2024 | 53.83M |
March 11, 2024 | 59.34M |
March 08, 2024 | 56.80M |
March 07, 2024 | 56.58M |
March 06, 2024 | 55.74M |
March 05, 2024 | 58.70M |
March 04, 2024 | 59.12M |
March 01, 2024 | 56.58M |
February 29, 2024 | 57.64M |
February 28, 2024 | 57.43M |
February 27, 2024 | 59.76M |
February 26, 2024 | 58.91M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
34.11M
Minimum
Apr 30 2024
943.55M
Maximum
Jan 27 2021
366.84M
Average
364.52M
Median
Apr 26 2022
Enterprise Value Benchmarks
TruBridge Inc | 312.22M |
Streamline Health Solutions Inc | 29.33M |
R1 RCM Inc | 6.828B |
LifeMD Inc | 488.44M |
LENZ Therapeutics Inc | 347.34M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -2.027M |
Revenue (Quarterly) | 65.32M |
Total Expenses (Quarterly) | 68.39M |
EPS Diluted (Quarterly) | -0.10 |
Gross Profit Margin (Quarterly) | 27.38% |
Profit Margin (Quarterly) | -3.10% |
Earnings Yield | -9.35% |
Normalized Earnings Yield | -9.345 |